Grace Therapeutics, Inc. Common Stock

GRCE us
$2.12
▼ 0.04 (-1.85%)
Volume: 79,718 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 36
  • 21d momentum -1.4%
  • MA aligned bearish
  • RSI 46
🎯 Pullback 50
  • -1.4% vs 20MA
💎 Value 58
  • -59% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)46.0
MACD-0.002
MA trendBearish
ATR4.70%
21d mom.-1.4%
63d mom.-10.9%
vs 20MA-1.4%
RVOL(20)0.52×
52w low · 2 52w high · 5
-59.1% from 52-week high
20d support 2 · resistance 2

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$45M
PER—
PBR0.94
PSR—
EPS$-0.96
ROE-41.9%
ROA-40.4%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-3.06
week1M3M6M1YYTD
+0.47% -1.40% -10.92% -55.56% -31.61% -42.08%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
5/10
🐻 Bear
6/10

14d momentum +0.95%, daily vol 2.12%. Grace Therapeutics, Inc. Common Stock sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.